Context Capital Management LLC Makes New $31,000 Investment in Ocean Biomedical, Inc. (NASDAQ:OCEAW)

Context Capital Management LLC bought a new stake in shares of Ocean Biomedical, Inc. (NASDAQ:OCEAW – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 111,755 shares of the company’s stock, valued at approximately $31,000. Ocean Biomedical Price Performance Shares […]

Related Keywords

,Ocean Biomedical Company Profile ,Nasdaq ,Exchange Commission ,Ocean Biomedical Inc ,Context Capital Management ,Ocean Biomedical ,Free Report ,Idiopathic Pulmonary Fibrosis ,Ocean Biomedical Daily ,Nasdaq Oceaw ,Oceaw ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,